Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Scientific, LGC Ink Distribution Pact

NEW YORK (GenomeWeb) – LGC will distribute Douglas Scientific's Array Tape laboratory automation platform in Europe, the Middle East, and Africa, according to an agreement announced today.

Douglas Scientific is headquartered in Alexandria, Minn. Its Array Tape platform consists of a liquid handling and assay processing system, a PCR waterbath, a detection instrument, and software. The platform is "highly compatible" with Hoddesdon, UK-based LGC's KASP genotyping assays and reagents, the companies said in a statement.

"This relationship is more than extending the reach of our individual product offerings," said Darren Cook, executive vice president of business development and strategy at Douglas Scientific. "It's about the alignment of two compelling missions."

This is the second such distribution pact for Douglas Scientific this year. As PCR Insider reported in January, the company inked a similar agreement with EnviroLogix to distribute EnviroLogix's DNAble technology with its Array Tape platform.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.